Novartis
NVS
848 hedge funds and large institutions have $21.5B invested in Novartis in 2014 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 291 increasing their positions, 341 reducing their positions, and 48 closing their positions.
63% more call options, than puts
Call options by funds: $171M | Put options by funds: $105M
44% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 48
6% more capital invested
Capital invested by funds: $20.2B → $21.5B (+$1.24B)
2% more funds holding
Funds holding: 831 → 848 (+17)
0.04% less ownership
Funds ownership: 10.65% → 10.61% (-0.04%)
3% less funds holding in top 10
Funds holding in top 10: 60 → 58 (-2)
15% less repeat investments, than reductions
Existing positions increased: 291 | Existing positions reduced: 341
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$409M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$97.8M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$70.3M |
| 4 |
Parnassus Investments
San Francisco,
California
|
+$37.9M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$34.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$145M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$122M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$101M |
| 4 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$87.1M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$71.3M |
NVS Hedge Fund Activity: Q2 2014 in Review
848 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q2 2014, worth a combined $21.5B — up 6.1% from $20.2B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new NVS positions and 48 closed out — a net gain of 21 holders — while 291 added to existing stakes and 341 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $409M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $145M.
- 848 institutional investors held Novartis (NVS) as of Q2 2014, up from 831 in Q1 2014.
- Funds reported $21.5B of Novartis stock for Q2 2014, up 6.1% quarter-over-quarter.
- 69 funds opened new Novartis positions in Q2 2014 and 48 closed out, a net change of +21 holders.
- The largest Novartis buyer in Q2 2014 was Dodge & Cox, an estimated $409M added.
- The largest Novartis seller in Q2 2014 was Hotchkis & Wiley Capital Management, an estimated $145M sold.
Based on aggregated 13F filings for Q2 2014.